CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) Posts Basic Consolidated EPS Of $-3.0523

0

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD)managed to report annual basic consolidated EPS of $-3.0523, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-3.0523 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-1.0643.

EPS contribution from parent

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) received of $-3.0523 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) contributed EPS of $-3.0523 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-3.0523.

What About Basic net EPS

The basic net EPS that CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) reported for the year ended 2015-12-31 stood at $-3.82. For the quarter ended 2015-12-31, the company posted basic net EPS of $-3.82.

What About Consolidated Diluted EPS?

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-3.0523. For the quarter ended 2015-12-31 the metric was$-3.0523.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-3.0523 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-3.0523.

Net diluted EPS

Net diluted EPS posted by CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) for the year ended 2015-12-31 was $-3.82. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-3.82.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) said that it parent company boosted its diluted EPS by$-3.0523 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-3.0523.

The company reported net basic EPS of $-3.82 for the year ended 2015-12-31 and net basic EPS of $-3.82 for the quarter ended 2015-12-31.

The number of CoLucid Pharmaceuticals Inc (NASDAQ:CLCD)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 10.071. That compares with 10.071 basic shares outstanding for the quarter ended 2015-12-31.

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) had 10.071 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 10.071.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 12 times, 1 visits today)